Clinical Trials
4 trialsNCT04895358 2026-03-11
KEYNOTE-B49
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT04799249 2024-08-01
PRESERVE 2
G1 Therapeutics, Inc.
Phase 3 Completed
NCT03457779 2021-10-08
Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer
Baylor Research Institute
Phase NA Completed
NCT02012608 2019-05-29
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
University of Arkansas
Phase 2 Terminated